Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children.

alkiviadis.1961 shared this article with you from Inoreader Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children. Via Vaccine CONCLUSIONS: PCV may protect high-risk children against pneumococcal colonization and mucosal disease by inducing mucosal antibody responses and priming for mucosal immune memory that results in mucosal immune responses after booster PPV. Saliva can be a convenient alternative sample to serum to study PCV-induced systemic IgG responses. PMID: 33121845 [PubMed - as supplied by publisher] (Source: Vaccine) View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.